redirect to https://www.japantimes.co.jp/news/2021/10/11/world/astrazeneca%2Dantibody%2Ddrug%2Dtrial/<script>window.location.href = 'mailto:?subject=astrazeneca drug effective at treating mild covid-19 symptoms in trial&body=https://www.japantimes.co.jp/news/2021/10/11/world/astrazeneca%2Dantibody%2Ddrug%2Dtrial/';setTimeout(function(){window.location.href= 'https://www.japantimes.co.jp/news/2021/10/11/world/astrazeneca%2Dantibody%2Ddrug%2Dtrial/'},500);</script>